CURE's Top 5 Stories: March 2019

Here are the top 5 CURE stories for March 2019.
BY Jessica Skarzynski
PUBLISHED April 01, 2019
Here are the top 5 CURE stories for March 2019.

5. FDA Approves First Immunotherapy For Breast Cancer 
In early March, the Food and Drug Administration (FDA) approved the frontline combination of Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for patients with unresectable locally advanced or metastatic PD-L1–positive triple-negative breast cancer.

4. Supporting Others Who Are Dealing With Cancer
People adjusting to cancer need space, but they also need to know they are loved and cared for. Here, one survivor shares her suggestions on how to talk with someone who is coping with their own diagnosis.

3. Immune-Boosting Foods
In this new feature of CURE’s sister publication, Heal, an expert from John Theurer Cancer Center shares three recipes filled with powerful germ-fighting, health-promoting properties.

2. Blood Cancers’ Bottom Line
We take a closer look at the high out-of-pocket medical care costs that patients with blood cancer and their families face in this piece.

1. Please Stop Calling It Hospice When I’m Very Much Alive
One is meant to improve quality of life and the other is end-of-life care. Yet palliative and hospice care still continue to be confused not only by patients, but also providers, as contributor Sarah DeBord details in her latest blog.

And as always, for links to all of our top stories and more, visit
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Breast Cancer CURE discussion group.

Related Articles


Sign In

Not a member? Sign up now!

Sign Up

Are you a member? Please Log In